DeepMed Research

BAYLOR COLLEGE OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1900-10-30

Employees: 10K

Market Cap: -

Website: http://www.bcm.edu

Clinical Trials

Auricular Acupuncture As Part Of A Multimodal Regimen After Distal Radius Open Reduction and Internal Fixation

Not Applicable

Recruiting

Conditions: Radius Fracture Distal
Pain, Postoperative

Interventions: Device: Acupuncture

First Posted Date: 2023-08-03

Last Posted Date: 2025-01-14

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 140

Registration Number: NCT05974254

Locations: 🇺🇸
Ben Taub Hospital, Houston, Texas, United States

Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

Not Applicable

Recruiting

Conditions: Cholelithiasis
Vomiting, Postoperative
Nausea, Postoperative
Cholecystitis, Acute
Pain, Postoperative

Interventions: Device: Acupuncture

First Posted Date: 2023-08-03

Last Posted Date: 2025-01-15

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 300

Registration Number: NCT05975385

Locations: 🇺🇸
Ben Taub Hospital, Houston, Texas, United States

Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder

Not Applicable

Recruiting

Conditions: Separation Anxiety
Obsessive-Compulsive Disorder in Children
Anxiety Disorder of Childhood
Obsessive-Compulsive Disorder in Adolescence
Social Anxiety Disorder of Childhood
Panic Disorder
Panic Attacks
Generalized Anxiety Disorder
Panic Disorder With Agoraphobia

Interventions: Other: Relaxation and Mentorship
Behavioral: Bibliotherapy, low therapist contact SPACE
Behavioral: Family Based, Internet-Based Cognitive Behavioral Therapy

First Posted Date: 2023-08-01

Last Posted Date: 2024-06-21

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 100

Registration Number: NCT05967468

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma

Phase 1

Recruiting

Conditions: Mesothelioma

Interventions: Drug: Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab
Drug: Durvalumab / tremelimumab

First Posted Date: 2023-07-06

Last Posted Date: 2024-08-26

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 52

Registration Number: NCT05932199

Locations: 🇺🇸
Baylor St Lukes, Houston, Texas, United States
🇺🇸
Duke Cancer Institute, Durham, North Carolina, United States

Brain Recordings in Patients Undergoing Deep Brain Stimulation (DBS) for Severe Obsessive-Compulsive Disorder (OCD)

Active, not recruiting

Conditions: Obsessive-Compulsive Disorder

First Posted Date: 2023-06-23

Last Posted Date: 2024-08-02

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 8

Registration Number: NCT05915741

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Utilization of Airway Stabilizing Rod

Not Applicable

Completed

Conditions: Airway Complication of Anesthesia

Interventions: Device: Time to Intubation using FASTER device

First Posted Date: 2023-06-12

Last Posted Date: 2024-12-05

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 20

Registration Number: NCT05899868

Locations: 🇺🇸
Texas Children's Hosppital, Houston, Texas, United States

Integrating Food Rx With Best Feeding Practices With EFNEP

Not Applicable

Recruiting

Conditions: Dietary Habits
Childhood Obesity
Food Selection
Feeding Behavior

Interventions: Behavioral: Revised ESBA

First Posted Date: 2023-05-31

Last Posted Date: 2024-08-29

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 30

Registration Number: NCT05881759

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Intracranial Investigation of Neural Circuity Underlying Human Mood

Not Applicable

Recruiting

Conditions: Depression
Epilepsy

Interventions: Device: sEEG Stimulation
Device: Brain Stimulation

First Posted Date: 2023-05-23

Last Posted Date: 2025-02-13

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 58

Registration Number: NCT05871372

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER

Phase 2

Recruiting

Conditions: Stage II Colon Cancer
Stage III Colon Cancer
Stage I Colon Cancer

Interventions: Drug: Tecentriq 1200 MG in 20 ML Injection + Capecitabine 1000 mg/m2 + Oxaliplatin 130 mg/m2
Drug: Oxaliplatin injection 85mg/m2 + Leucovorin 400mg/m2 + 5-Fluorouracil 2400mg/m2
Drug: Oxaliplatin 130mg/m2 + Capecitabine 1000mg/m2

First Posted Date: 2023-05-23

Last Posted Date: 2025-02-03

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 28

Registration Number: NCT05870800

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States

High Dose Albumin in Refractory Ascites

Phase 2

Recruiting

Conditions: Ascites

Interventions: Drug: Albumin

First Posted Date: 2023-05-22

Last Posted Date: 2024-08-29

Lead Sponsor: Baylor College of Medicine

Target Recruit Count: 100

Registration Number: NCT05867602

Locations: 🇺🇸
Baylor St' Lukes Medical center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy